Technology for
physiotherapy delivery in the ICU to prevent ICU-acquired weakness

What is ICU-acquired weakness

Muscle at ICU admission (light grey)

Same muscle 6 months post-ICU discharge

Patients ventilated and sedated in the ICU are most at risk of developing ICU-acquired weakness. Muscle loss can progress as quickly as 2-4% per day. 50% of patients 65 or older, on a ventilator in the ICU for a week or more experience permanent disability.

Increased health care costs

The average cost of care for long-term ventilation survivors 1 year post-ICU discharge is $82,000 per year. This costs the health care system over $22 billion per year in North America.

Improving Physical Therapy
Delivery in the ICU

About Us

Elaya develops solutions that enable neuromuscular electrical stimulation therapy in the ICU to prevent ICUAW, improve patient outcomes and post-ICU quality of life.

These innovations enable effective therapy delivery to multiple patients in the ICU and provide valuable insights for evidence-based personalized care. 

Partners

We are working with our hospital, university and college partners to develop our technology, gather data, and test our designs.

Contact Us